Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540)

Wang Yin; Celine Loinard; Wineke Bakker; Coralie L. Guerin; Jose Vilar; Clement DAudigier; Laetitia Mauge; Patrick Bruneval; Joseph Emmerich; Bernard I. Levy; Jacques Pouyssegur; David M. Smadja; Jean Sebastien Silvestre

doi:10.1002/stem.1652

Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540)

Wang Yin, Celine Loinard, Wineke Bakker, Coralie L. Guerin, Jose Vilar, Clement DAudigier, Laetitia Mauge, Patrick Bruneval, Joseph Emmerich, Bernard I. Levy, Jacques Pouyssegur, David M. Smadja, Jean Sebastien Silvestre

Luxembourg Institute of Health

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1056
Number of pages	1
Journal	Stem Cells
Volume	32
Issue number	4
DOIs	https://doi.org/10.1002/stem.1652
Publication status	Published - Apr 2014

Access to Document

10.1002/stem.1652

Cite this

Yin, W., Loinard, C., Bakker, W., Guerin, C. L., Vilar, J., DAudigier, C., Mauge, L., Bruneval, P., Emmerich, J., Levy, B. I., Pouyssegur, J., Smadja, D. M., & Silvestre, J. S. (2014). Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540). Stem Cells, 32(4), 1056. https://doi.org/10.1002/stem.1652

@article{2943120494ef461381940c6373c51f03,

title = "Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540)",

author = "Wang Yin and Celine Loinard and Wineke Bakker and Guerin, {Coralie L.} and Jose Vilar and Clement DAudigier and Laetitia Mauge and Patrick Bruneval and Joseph Emmerich and Levy, {Bernard I.} and Jacques Pouyssegur and Smadja, {David M.} and Silvestre, {Jean Sebastien}",

year = "2014",

month = apr,

doi = "10.1002/stem.1652",

language = "English",

volume = "32",

pages = "1056",

journal = "Stem Cells",

issn = "1066-5099",

publisher = "Oxford University Press",

number = "4",

}

Yin, W, Loinard, C, Bakker, W, Guerin, CL, Vilar, J, DAudigier, C, Mauge, L, Bruneval, P, Emmerich, J, Levy, BI, Pouyssegur, J, Smadja, DM & Silvestre, JS 2014, 'Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540)', Stem Cells, vol. 32, no. 4, pp. 1056. https://doi.org/10.1002/stem.1652

Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540). / Yin, Wang; Loinard, Celine; Bakker, Wineke et al.
In: Stem Cells, Vol. 32, No. 4, 04.2014, p. 1056.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540)

AU - Yin, Wang

AU - Loinard, Celine

AU - Bakker, Wineke

AU - Guerin, Coralie L.

AU - Vilar, Jose

AU - DAudigier, Clement

AU - Mauge, Laetitia

AU - Bruneval, Patrick

AU - Emmerich, Joseph

AU - Levy, Bernard I.

AU - Pouyssegur, Jacques

AU - Smadja, David M.

AU - Silvestre, Jean Sebastien

PY - 2014/4

Y1 - 2014/4

UR - http://www.scopus.com/inward/record.url?scp=84896340871&partnerID=8YFLogxK

U2 - 10.1002/stem.1652

DO - 10.1002/stem.1652

M3 - Comment/debate

AN - SCOPUS:84896340871

SN - 1066-5099

VL - 32

SP - 1056

JO - Stem Cells

JF - Stem Cells

IS - 4

ER -

Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540)

Access to Document

Other files and links

Cite this